This site is intended for healthcare professionals only
LoginRegister

Pulmonology Dialogues

Abnormal CT findings may persist for one year among COVID-19 patients after recovery

Abnormal CT findings may persist for one year among COVID-19 patients after recovery

A new study published in The Chest Journal suggests that one year following recovery, COVID-19 patients frequently had persistent computed tomography...
View All

Latest News and Guidelines

Dupilumab reduces exacerbations and improves FEV1 in uncontrolled, moderate-to-severe asthma

Dupilumab reduces exacerbations and improves FEV1 in uncontrolled, moderate-to-severe asthma

Catheter-Directed Thrombolysis exhibits impressive results in patients with Intermediate-Risk Pulmonary Embolism: JAMA

Catheter-Directed Thrombolysis exhibits impressive results in patients with Intermediate-Risk...

Combo therapy of elexacaftor, tezacaftor, and ivacaftor improves sinonasal outcomes in cystic fibrosis: Study

Combo therapy of elexacaftor, tezacaftor, and ivacaftor improves sinonasal outcomes in cystic...

Low-dose steroids reduce time on ventilators and preserve heart in premature infants, study

Low-dose steroids reduce time on ventilators and preserve heart in premature infants, study

Pulmonary infections with nontuberculous mycobacteria on the rise globally

Pulmonary infections with nontuberculous mycobacteria on the rise globally

United Airway Disease and Clinical Applicability of Montelukast Fexofenadine Combination: Review

United Airway Disease and Clinical Applicability of Montelukast Fexofenadine Combination: Review

View All
X